Company News for Mar 16, 2026

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Stocks Company News for Mar 16, 2026 March 16, 2026 — 05:47 am EDT Written by Zacks Equity Research for Zacks-> Adobe Inc.’s (ADBE) shares tumbled 7.6%, after the company announced that its longtime CEO Shantanu Narayen will step down once a successor is appointed.Shares of Meta Platforms Inc. (META) slid 3.8% following news that the company has delayed the release of its new AI model "Avocado" to at least May. Shares of Nektar Therapeutics (NKTR) surged 4.1% after reporting fourth-quarter 2025 adjusted loss of $1.78 per share, narrower than the Zacks Consensus Estimate of an adjusted loss of $2.76 per share.

Oruka Therapeutics Inc.’s (ORKA) shares soared 25% after posting fourth-quarter 2025 adjusted loss of $0.45 per share, narrower than the Zacks Consensus Estimate of an adjusted loss of $0.61 per share. Zacks' Research Chief Picks Stock Most Likely to "At Least Double" Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportAdobe Inc. (ADBE) : Free Stock Analysis ReportNektar Therapeutics (NKTR) : Free Stock Analysis ReportMeta Platforms, Inc. (META) : Free Stock Analysis ReportOruka Therapeutics, Inc. (ORKA) : Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags StocksInvestingHow to Invest Zacks Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com. More articles by this source-> Stocks mentioned ADBE NKTR META ORKA More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.